A case of progressive systemic scleroderma in a patient who had COVID-19: observation using computed tomography over time

A clinical case of a patient with systemic scleroderma who underwent COVID-19. In systemic scleroderma, pulmonary involvement is the most common cause of death in patients is presented. Residual
lung abnormalities after the patient's discharge from the hospital mainly include frosted-glass opacities, subpleural meshes, cystic changes, and parenchymatous traction.
These features are consistent with the imaging definition of interstitial lung abnormalities. In systemic scleroderma with pulmonary involvement, computed tomography is the main tool for screening and diagnosis, and its findings influence the choice of therapy and the dynamics of follow-up.
 CT scans can provide high-resolution volumetric images of the lungs. Such scans can facilitate visualization, characterization and quantification of the extent of diffuse lung diseases such as usual interstitial pneumonitis or idiopathic pulmonary fibrosis.

1. Khatabu, H., Hanninghake, G. M., Lynch, D. A. (2019). Interstitial lung abnormalities: recognition and prospects. Radiology, 291(1), 1-3.

2. Zou, H, Li, Sq. (2020). Pulmonary fibrosis in critically ill patients with novel coronavirus pneumonia during the recovery stage and suggestions for early intervention. Acta Pharmacol Sin 42, 1376-1378.

3. Harrison, A. G., Lin, T., Wang, P. (2020). Mechanisms of transmission and pathogenesis of SARSCoV-2. Trends Immunol. 41, 1100-1115.

4. Krishna Murthy, P. et al. (2021). Repurposing histone deacetylase inhibitors: a promising strategy to combat pulmonary fibrosis promoted by TGF-beta signaling in COVID-19 survivors. Life Science, 266.

5. Watanabe, A., So, M., Iwagami, M. et al. (2022). CT findings in patients with COVID-19 at one year: a systematic review and meta-analysis. Respirology, 27 (8), 605 – 616.

6. Tang, C. T., Xu, B. C., Chen, D. Y. (2021). Autoimmune and rheumatic manifestations associated with COVID-19 in adults: an updated systematic review. Front Immunol., 12, DOI: 10.3389/fimmu.2021.645013.

7. Han, X., Fan, Y., Alwalid, O. et al. (2021). Fibrotic Interstitial Lung Abnormalities at 1-year Follow-up CT after Severe COVID-19. Radiology, 301(3), DOI: https://pubs.rsna.org/doi/10.1148/radiol.2021210972.